论著

肥胖显著增加勃起功能障碍风险:一项基于观察性研究的荟萃分析

  • 姬阆 ,
  • 郝少龙 ,
  • 孙海涛 ,
  • 孙武青 ,
  • 马纪红 ,
  • 白日星 ,
  • 韩威
展开
  • 首都医科大学附属北京潞河医院 a.中心实验室b.普外科,c.医疗保健病区北京 101149
第一联系人:*: 共同第一作者
白日星,E-mail:brx5168@163.com
韩威,E-mail:dr-han1972@mail.ccmu.edu.cn

收稿日期: 2025-04-30

  网络出版日期: 2026-01-26

Obesity significantly increases the risk of erectile dysfunction: a meta-analysis based on observational studies

  • JI Lang ,
  • HAO Shaolong ,
  • SUN Haitao ,
  • SUN Wuqing ,
  • Ma Jihong ,
  • BAI Rixing ,
  • HAN Wei
Expand
  • a. Central Laboratory; b. Department of General Surgery; c. Department of Healthcare, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China

Received date: 2025-04-30

  Online published: 2026-01-26

摘要

目的:通过荟萃分析量化评估肥胖与勃起功能障碍(ED)风险的关联。方法:遵循PRISMA指南,系统检索中英文数据库(截至2025年3月),纳入观察性研究(队列、横断面、病例对照研究),提取调整后效应值(OR及95%CI)。采用美国卫生保健研究与质量局(AHRQ)量表评估研究质量,随机效应模型合并效应值,并通过亚组分析(地域、肥胖定义)和敏感性分析验证结果稳健性。结果:共纳入10项研究(n=230 744),9项为横断面研究。荟萃分析显示,肥胖显著增加ED风险(随机效应OR=1.80,95% CI: 1.29~2.51),异质性较高(I2=99.9%)。亚组分析表明,美国人群关联强度(OR=2.10,95% CI: 1.23~3.60)高于中国人群(OR=1.16,95% CI: 1.05~1.28);以BMI≥25 kg/m3为肥胖标准时,效应值最高(OR=3.05,95% CI: 2.06~4.51)。敏感性分析证实结果稳健(排除任一研究后OR波动范围1.60~1.94)。结论:肥胖是ED的重要危险因素,其效应强度受地域及肥胖定义影响。建议欧美人群以BMI≥30 kg/m2作为干预阈值,亚洲人群需关注BMI≥25 kg/m3的代谢风险。

本文引用格式

姬阆 , 郝少龙 , 孙海涛 , 孙武青 , 马纪红 , 白日星 , 韩威 . 肥胖显著增加勃起功能障碍风险:一项基于观察性研究的荟萃分析[J]. 外科理论与实践, 2025 , 30(06) : 494 -502 . DOI: 10.16139/j.1007-9610.2025.06.07

Abstract

Objective To quantify the association between obesity and erectile dysfunction (ED) risk through a meta-analysis. Methods Following PRISMA guidelines, systematic searches of Chinese and English databases (up to March 2025) were conducted to include observational studies (cohort, cross-sectional, case-control). Adjusted effect sizes (OR and 95% CI) were extracted. Study quality was assessed using the Agency for Healthcare Research and Quality(AHRQ) scale, and a random-effects model was applied to pool effect sizes. Subgroup analyses (geographic region, obesity definitions) and sensitivity analyses were performed to validate robustness. Results Ten studies (n=230 744), including nine cross-sectional studies, were included. The meta-analysis revealed that obesity significantly increased ED risk (random-effects OR=1.80, 95% CI: 1.29-2.51), with high heterogeneity (I2=99.9%). Subgroup analyses indicated stronger associations in USA populations (OR=2.10, 95% CI: 1.23-3.60) than in Chinese populations (OR=1.16, 95% CI: 1.05-1.28). The highest effect size was observed when using BMI≥25 kg/m3 as the obesity threshold (OR=3.05, 95% CI: 2.06-4.51). Sensitivity analyses confirmed robust results (OR: 1.60-1.94 after excluding any single study). Conclusions Obesity is a critical risk factor for ED, with effect strength influenced by geographic region and obesity definitions. Interventions targeting BMI≥30 kg/m2 in Western populations and metabolic risks at BMI≥25 kg/m3 in Asian populations are recommended.

参考文献

[1] World Health Organization. Obesity and overweight 2024[EB/OL]. Geneva: WHO. [2024-3-15]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
[2] NG M, FLEMING T, ROBINSON M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2014, 384(9945):766-781.
[3] ROSEN R C, WING R, SCHNEIDER S, et al. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors[J]. Urol Clin North Am, 2005, 32(4):403-417.
[4] CORONA G, VENA W, PIZZOCARO A, et al. Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study[J]. J Endocrinol Invest, 2023, 46(11):2195-2211.
[5] BESIROGLU H, OTUNCTEMUR A, OZBEK E. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies[J]. J Sex Med, 2015, 12(6):1309-1318.
[6] LIN W, LIN M E. Novel anthropometric measures are positively associated with erectile dysfunction: a cross-sectional study[J]. Int Urol Nephrol, 2024, 56(3):855-865.
[7] YANG B, WANG H, TANG L, et al. Relative fat mass, a better predictor of erectile dysfunction: insights from the NHANES 2001-2004[J]. Am J Mens Health, 2025, 19(1):15579883241311218.
[8] PAGE M J, MCKENZIE J E, BOSSUYT P M, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews[J]. BMJ, 2021,372:n71.
[9] FARQUHAR M. AHRQ Quality Indicators[M]//HUGHES R G. Patient Safety and Quality: An Evidence-based Handbook for Nurses. Rockville: AHRQ, 2008.
[10] HIGGINS J P T, THOMAS J, CHANDLER J, et al. Cochrane handbook for systematic reviews of interventions[M]. 2nd ed. Chichester (UK): John Wiley & Sons, 2019.
[11] XU M, ZHOU H, ZHANG R, et al. Correlation between visceral adiposity index and erectile dysfunction in American adult males: a cross-sectional study based on NHANES[J]. Front Endocrinol (Lausanne), 2023, 14:1301284.
[12] ANDERSEN I, HEITMANN B L, WAGNER G. Obesity and sexual dysfunction in younger Danish men[J]. J Sex Med, 2008, 5(11):2735.
[13] CHENG J Y, NG E M. Body mass index, physical activity and erectile dysfunction: an U-shaped relationship from population-based study[J]. Int J Obes (Lond), 2007, 31(10):1571-1578.
[14] FUNG M M, BETTENCOURT R, BARRETT-CONNOR E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study[J]. J Am Coll Cardiol, 2004, 43(8):1405-1411.
[15] HUANG L, LIU H, LI L, et al. Correlation between visceral fat metabolism score and erectile dysfunction: a cross-sectional study from NHANES 2001-2004[J]. Front Endocrinol (Lausanne), 2023, 14:1283545.
[16] PITTA R M, DE LIMA QUEIROGA L, LOUZADA ACS, et al. What are the main risk factors associated with erectile dysfunction in the elderly? A cross-sectional study of 2436 Brazilian elderly men[J]. Clin Interv Aging, 2023, 18:1047-1054.
[17] SUAREZ ARBELAEZ M C, NACKEERAN S, SHAH K, et al. Association between body mass index, metabolic syndrome and common urologic conditions: a cross-sectional study using a large multi-institutional database from the United States[J]. Ann Med, 2023, 55(1):2197293.
[18] YU Y, WANG Y, XU L, et al. Combined obesity- and lipid-related indices are associated with hypogonadism in Chinese male patients with type 2 diabetes: a cross-sectional study[J]. Front Endocrinol (Lausanne), 2024, 14:1319582.
[19] MILLER C, MADDEN-DOYLE L, JAYASENA C, et al. Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology[J]. Eur J Endocrinol, 2024, 191(6):R1-R17.
[20] MUIR C A, WITTERT G A, and HANDELSMAN D J. Approach to the patient: low testosterone concentrations in men with obesity[J]. J Clin Endocrinol Metab, 2025, 110(9):e3125-e3130.
[21] COLLELUORI G, CHEN R, TURIN C G, et al. Aromatase inhibitors plus weight loss improves the hormonal profile of obese hypogonadal men without causing major side effects[J]. Front Endocrinol (Lausanne), 2020, 11:277.
[22] AZAB S S, SALEM A, ISMAIL N N, et al. Penile hemodynamics study in erectile dysfunction men: the influence of smoking obesity on the parameters of penile duplex[J]. Int Urol Nephrol, 2020, 52(6):1015-1025.
[23] DE ROCCO PONCE M, QUINTIAN SCHWIETERS C F, MEZIERE J, et al. A study of the relationship between objective tests to diagnose erectile dysfunction and mar-kers of cardiovascular disease[J]. J Clin Med, 2024, 13(21):6321.
[24] DENG C Y, KE X P, GUO X G. Investigating a novel surrogate indicator of adipose accumulation in relation to erectile dysfunction[J]. Lipids Health Dis, 2024, 23(1):139.
[25] PIZZOL D, SMITH L, FONTANA L, et al. Associations between body mass index, waist circumference and erectile dysfunction: a systematic review and meta-analysis[J]. Rev Endocr Metab Disord, 2020, 21(4):657-666.
[26] HOU P H, MAO F C, CHANG G R, et al. Newly diagnosed bipolar disorder and the subsequent risk of erectile dysfunction: a nationwide cohort study[J]. J Sex Med, 2018, 15(2):183-191.
[27] ESPOSITO K, GIUGLIANO F, DI PALO C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial[J]. JAMA, 2004, 291(24):2978-2984.
[28] SCHAUER P R, KASHYAP S R, WOLSKI K, et al. Baria-tric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012, 366(17):1567-1576.
[29] ALBERTI K G, ZIMMET P, SHAW J, et al. The metabolic syndrome—a new worldwide definition[J]. Lancet, 2005, 366(9491):1059-1062.
文章导航

/